Preparation of ferrocene‑iridium(III) acylhydrazone complexes and their anticancer application against A549 cell line

IF 3.8 2区化学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Journal of Inorganic Biochemistry Pub Date : 2025-03-15 DOI:10.1016/j.jinorgbio.2025.112899

Wenzhi Yang , Jia Wen , Xicheng Liu , Jinfeng Liu

{"title":"Preparation of ferrocene‑iridium(III) acylhydrazone complexes and their anticancer application against A549 cell line","authors":"Wenzhi Yang , Jia Wen , Xicheng Liu , Jinfeng Liu","doi":"10.1016/j.jinorgbio.2025.112899","DOIUrl":null,"url":null,"abstract":"<div><div>Two ferrocene‑iridium(III) acylhydrazone complexes (<strong>Fe-Ir1</strong> and <strong>Fe-Ir2</strong>) were designed and synthesized, which showed excellent anti-proliferative activity against A549 human lung adenocarcinoma and A549/DDP (cisplatin-resistant) cell lines, especially for <strong>Fe-Ir1</strong> (IC<sub>50</sub> = 10.2 ± 0.4 μM, twice that of cisplatin). Meanwhile, <strong>Fe-Ir1</strong> showed low toxicity to BEAS-2B cells (normal dividing human bronchial epithelial cells), indicating its favorable selectivity. <strong>Fe-Ir1</strong> entered A549 cells following an non-energy-dependent pathway, targeted lysosomes, induced changes in lysosomal membrane permeability, reduced glycolytic stress, arrested cell cycle, then promoted early-stage apoptosis and effectively inhibited cell migration. Western blotting also showed that the <strong>Fe-Ir1</strong> could promote the expression of Bax protein and inhibited Bcl-2 and PARP protein in A549 cells. In vivo experiments demonstrated that <strong>Fe-Ir1</strong> had significant capabilities in inhibiting tumor growth, cancer cell metastasis and spread. In conclusion, <strong>Fe-Ir1</strong> holds promise as a potential alternative to platinum-based drugs and warrants further research, offering more hope and vitality to cancer patients.</div></div>","PeriodicalId":364,"journal":{"name":"Journal of Inorganic Biochemistry","volume":"269 ","pages":"Article 112899"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inorganic Biochemistry","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0162013425000790","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Two ferrocene‑iridium(III) acylhydrazone complexes (Fe-Ir1 and Fe-Ir2) were designed and synthesized, which showed excellent anti-proliferative activity against A549 human lung adenocarcinoma and A549/DDP (cisplatin-resistant) cell lines, especially for Fe-Ir1 (IC₅₀ = 10.2 ± 0.4 μM, twice that of cisplatin). Meanwhile, Fe-Ir1 showed low toxicity to BEAS-2B cells (normal dividing human bronchial epithelial cells), indicating its favorable selectivity. Fe-Ir1 entered A549 cells following an non-energy-dependent pathway, targeted lysosomes, induced changes in lysosomal membrane permeability, reduced glycolytic stress, arrested cell cycle, then promoted early-stage apoptosis and effectively inhibited cell migration. Western blotting also showed that the Fe-Ir1 could promote the expression of Bax protein and inhibited Bcl-2 and PARP protein in A549 cells. In vivo experiments demonstrated that Fe-Ir1 had significant capabilities in inhibiting tumor growth, cancer cell metastasis and spread. In conclusion, Fe-Ir1 holds promise as a potential alternative to platinum-based drugs and warrants further research, offering more hope and vitality to cancer patients.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Inorganic Biochemistry 生物-生化与分子生物学

CiteScore

7.00

自引率

10.30%

发文量

336

审稿时长

41 days

期刊介绍： The Journal of Inorganic Biochemistry is an established international forum for research in all aspects of Biological Inorganic Chemistry. Original papers of a high scientific level are published in the form of Articles (full length papers), Short Communications, Focused Reviews and Bioinorganic Methods. Topics include: the chemistry, structure and function of metalloenzymes; the interaction of inorganic ions and molecules with proteins and nucleic acids; the synthesis and properties of coordination complexes of biological interest including both structural and functional model systems; the function of metal- containing systems in the regulation of gene expression; the role of metals in medicine; the application of spectroscopic methods to determine the structure of metallobiomolecules; the preparation and characterization of metal-based biomaterials; and related systems. The emphasis of the Journal is on the structure and mechanism of action of metallobiomolecules.

期刊最新文献

Preparation of ferrocene‑iridium(III) acylhydrazone complexes and their anticancer application against A549 cell line Editorial Board Contents continued Graphical abstract TOC Graphical abstract TOC